Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - HEALTH DISCOVERY CORPt82579_ex99-1.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported):  June 16, 2015

 

 

Health Discovery Corporation

(Exact name of registrant as specified in charter)

 

 

Georgia 333-62216 74-3002154
(State of incorporation) (Commission File Number)

(IRS Employer

Identification No.)

 

 

4243 Dunwoody Club Drive, Suite 202, Atlanta GA  30350

(Address of principal executive offices / Zip Code)

 

 

(678) 336-5300

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 

  o Written communications pursuant to Rule 425 under the Securities Act.
  o Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
  o Pre-commencement communications pursuant to Rule 14d—2(b) under the Exchange Act.
  o Pre-commencement communications pursuant to Rule 13e—4(c) under the Exchange Act.

 

 
 

 

ITEM 8.01 Other Events

 

In January 2007, SVM Capital, LLC (“SVM Capital”) was formed as a joint venture between Health Discovery Corporation (“HDC”) and Atlantic Alpha Strategies, LLC (“Atlantic Alpha”) to explore and exploit the potential applicability of HDC’s SVM technology to quantitative investment management techniques.  On June 16, 2015, SVM Capital joined Manifold Partners, LLC (“ Manifold Partners”) as a partner.

 

On June 16, 2015, Manifold Partners issued a press release announcing SVM Capital joining Manifold Partners. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.

 

ITEM 9.01 Financial Statements and Exhibits

  

  (a) Not applicable
  (b) Not applicable
  (c) Not applicable
  (d) Exhibits
     
    99.1     Press Release Manifold Partners, LLC dated June 16, 2015.

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

 

  HEALTH DISCOVERY CORPORATION

 

 

 

 

   
       
Dated:  June 17, 2015 By: /s/ Kevin Kowbel  
    Chairman & Interim Chief Executive Officer